Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy

Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy / Mappa, ; Marturano, ; Licata, ; Frezzato, ; Frungillo, ; Ilariucci, ; Stelitano, ; Ferrari, ; Sorarù, ; Vianello, ; Baldini, ; Proserpio, ; Foppoli, ; Assanelli, ; Reni, M; Caligaris-Cappio, ; Ferreri, ; A. J., M.. - In: HEMATOLOGICAL ONCOLOGY. - ISSN 0278-0232. - (2013).